Blueberin

each tablet contains 250 mg of water extracted spring blueberry leaves, containing minimum 50 mg CA and 50 mg myricetin flavonoid isolated and purified from bayberry

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Abidov, M: 1 article (12/2006)
2.	Chkhikvishvili, I: 1 article (12/2006)
3.	Jimenez Del Rio, M: 1 article (12/2006)
4.	Ramazanov, A: 1 article (12/2006)

Related Diseases

1.

Type 2 Diabetes Mellitus (MODY) 12/01/2006 - "Effect of Blueberin on fasting glucose, C-reactive protein and plasma aminotransferases, in female volunteers with diabetes type 2: double-blind, placebo controlled clinical study." 12/01/2006 - "In a 4-week randomized placebo-controlled clinical trial we investigated the effect of 300 mg Blueberin, a phytomedicine containing 250 mg Blueberry leaves (Vaccinium arctostaphylos L, Ericaceae) extract providing minimum 50 mg 3,4-caffeoylquinic (chlorogenic) acid, and 50 mg myricetin, on fasting plasma glucose, alanine aminotransferases (ALT), aspartate aminotransferases (AST), glutamyltransferase (GGT) enzymes levels, and serum inflammatory C-Reactive proteins (CRP) in forty-two volunteer subjects (46+/-15 year of age, BMI 25+/-3 kgs/(m2)) diagnosed with Type 2 diabetes. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)
2.	Glucose (Dextrose)
3.	Enzymes
4.	Chlorogenic Acid
5.	C-Reactive Protein
6.	Aspartate Aminotransferases (Aspartate Transaminase)
7.	Transaminases (Aminotransferases)
8.	Alanine (L-Alanine)
9.	myricetin